Adherence of ticagrelOr in real world patients with aCute coronary syndrome: The AD-HOC study

Adherence of ticagrelOr in real world patients with aCute coronary syndrome: The AD-HOC study

Background: Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor antagonist is the cornerstone of therapy in patients with acute coronary syndrome (ACS). Adherence to medical therapy is an important issue, as premature DAPT discontinuation increases the risk of new ischemic events. The...

Full description

Bibliographic Details
Main Authors:	Luigi Fiocca, Roberta Rossini, Greta Carioli, Alessandra Carobbio, Isabelle Piazza, Elona Collaku, Simona Giubilato, Francesco Amico, Maria Molfese, Mauro De Benedictis, Paolo Calabria, Ugo Limbruno, Serafina Valente, Marco Ferlini, Tiziana Spezzano, Michele Senni, Antonello Gavazzi
Format:	Article
Language:	English
Published:	Elsevier 2022-10-01
Series:	International Journal of Cardiology: Heart & Vasculature
Subjects:	Acute coronary syndrome Dual antiplatelet therapy Ticagrelor Discontinuation Adherence
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352906722001415

Similar Items

Ticagrelor
by: Gianluca Airoldi, et al.
Published: (2013-03-01)

Ticagrelor versus clopidogrel in the management of acute myocardial infarction
by: Candice Volney, et al.
Published: (2019-07-01)

Factors Determining Ticagrelor-Induced Dyspnea in Patients with Acute Coronary Syndrome
by: Vytenis Tamakauskas, et al.
Published: (2022-10-01)

Ticagrelor and Eptifibatide Bolus Versus Ticagrelor and Eptifibatide Bolus With 2‐Hour Infusion in High‐Risk Acute Coronary Syndromes Patients Undergoing Early Percutaneous Coronary Intervention
by: Moazez J. Marian, et al.
Published: (2017-11-01)

A life-threatening massive hemoptysis case in the course of dual antiplatelet therapy with ticagrelor
by: Dimitrios Molyvas, et al.
Published: (2022-09-01)

Age‐Dependent Effect of Ticagrelor Monotherapy Versus Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events: A Post Hoc Analysis of the TICO Randomized Trial
by: Byung Gyu Kim, et al.
Published: (2021-12-01)

No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy
by: Viviana Laredo, et al.
Published: (2020-05-01)

A Therapeutic Pathway in Patients with Chronic Coronary Syndromes: Proposal for Optimization
by: Raffaele De Caterina, et al.
Published: (2022-04-01)

Ticagrelor versus clopidogrel after intracranial stent angioplasty: a real-world study
by: Lili Sun, et al.
Published: (2023-08-01)

Aspirin or Ticagrelor in Staphylococcus aureus Infective Endocarditis: Where Do We Stand?
by: Kirsten Leeten, et al.
Published: (2021-10-01)

Comparison of Clinical Outcomes Between Ticagrelor and Clopidogrel in Elderly Patients Undergoing Percutaneous Coronary Intervention: A Cohort Study
by: Meng S, et al.
Published: (2022-04-01)

Effect of ticagrelor versus clopidogrel after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome—propensity score matching analysis
by: Yinan Zhao, et al.
Published: (2024-01-01)

Ticagrelor plus aspirin in patients with minor ischemic stroke and transient ischemic attack: a network meta-analysis
by: Mingxia Li, et al.
Published: (2023-08-01)

Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS–TIMI 54
by: Marc P. Bonaca, et al.
Published: (2018-11-01)

Ticagrelor vs. Clopidogrel After Complex Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease
by: Ziwei Xi, et al.
Published: (2021-11-01)

Walking the Line with Ticagrelor: Meta-Analysis Comparing the Safety and Efficacy of Ticagrelor Monotherapy after a Short Course of Ticagrelor-Based Dual Antiplatelet Therapy versus Standard Therapy in Complex Percutaneous Coronary Intervention
by: Francesco Condello, et al.
Published: (2021-11-01)

Implementation of Ticagrelor Reduced Mortality in Routine Clinical Care: Evidence From a Natural Experiment Including 109 995 Patients With Myocardial Infarction in Sweden
by: Kasper Johannesen, et al.
Published: (2023-03-01)

Hospital‐Level Variation in Ticagrelor Use in Patients With Acute Coronary Syndrome
by: Aya F. Ozaki, et al.
Published: (2022-07-01)

Ticagrelor – toward more efficient platelet inhibition and beyond
by: Kubisa MJ, et al.
Published: (2018-01-01)

Clopidogrel versus ticagrelor in East Asian patients aged 75 years or older with acute coronary syndrome: observations from the GF-APT registry
by: Ziwei Xi, et al.
Published: (2022-11-01)

Body mass index affecting ticagrelor monotherapy vs. ticagrelor with aspirin in patients with acute coronary syndrome: A pre-specified sub-analysis of the TICO randomized trial
by: Byung Gyu Kim, et al.
Published: (2023-03-01)

Systemic Design and Evaluation of Ticagrelor-Loaded Nanostructured Lipid Carriers for Enhancing Bioavailability and Antiplatelet Activity
by: Gi-Ho Son, et al.
Published: (2019-05-01)

Antiplatelet efficacy of ticagrelor versus clopidogrel in Mediterranean patients with diabetes mellitus and chronic coronary syndromes: A crossover pharmacodynamic investigation
by: Ana Lucrecia Marcano, et al.
Published: (2022-11-01)

Comparisons between ticagrelor and clopidogrel following percutaneous coronary intervention in patients with acute coronary syndrome: a comprehensive meta-analysis
by: Fan ZG, et al.
Published: (2019-02-01)

Ticagrelor in patients with stable coronary artery disease: a role in improving prognosis
by: T. N. Novikova
Published: (2020-09-01)

Association of ADP-Induced Whole-Blood Platelet Aggregation with Serum Low-Density Lipoprotein Cholesterol in Patients with Coronary Artery Disease When Receiving Maintenance Ticagrelor-Based Dual Antiplatelet Therapy
by: Bernadeta Chyrchel, et al.
Published: (2023-07-01)

Ticagrelor monotherapy after a short course of dual antiplatelet therapy with ticagrelor plus aspirin following percutaneous coronary intervention in patients with versus without diabetes mellitus: a meta-analysis of randomized trials
by: Chen Ning, et al.
Published: (2024-03-01)

PROLONGED DUAL ANTIPLATELET THERAPY AFTER MYOCARDIAL INFARCTION: WHAT THE RESULTS OF THE PEGASUS-TIMI 54 TRIAL SHOW
by: I. S. Yavelov
Published: (2017-09-01)

ALTERNATIVE APPROACHES TO THE USE OF TWO COMPONENT ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME: EVIDENCES, RECOMMENDATIONS AND REAL PRACTICE
by: S. R. Gilyarevskiy, et al.
Published: (2015-12-01)

The Role of Ticagrelor in STEMI Fibrinolytic and Its Rationale to Utilize for Indonesian Patients
by: Daniel Tobing, et al.
Published: (2019-09-01)

Effects of Body Mass Index and Body Weight on Plasma Concentration of Ticagrelor and Platelet Aggregation Rate in Patients with Unstable Angina in a Chinese Han Population
by: Houling Guo, et al.
Published: (2024-03-01)

Real-World Use of Clopidogrel and Ticagrelor in Patients With Myocardial Infarction With Nonobstructive Coronary Arteries: Patient Characteristics and Long-Term Outcomes
by: Side Gao, et al.
Published: (2021-12-01)

Reacción de hipersensibilidad a ticagrelor
by: Jorge Alberto Castro Clavijo, et al.
Published: (2020-02-01)

Fifteen-Year Nationwide Trend in Antiplatelet Treatment among Drug-Eluting Stent Recipients in Korea: Many Patients Receive Very Prolonged Dual-Antiplatelet Treatment, and Newer Drugs Are Replacing the Older Ones
by: Sunwon Kim, et al.
Published: (2023-04-01)

A Case Report of Ticagrelor-Induced Thrombocytopenia
by: Alsalman M
Published: (2023-07-01)

The Effect of Platelet Activity, ABCB1 Genetic Polymorphism, and Renal Function on the Development of Ticagrelor-Related Dyspnea in Patients with Acute Coronary Syndrome
by: Tamakauskas V, et al.
Published: (2024-01-01)

Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial
by: Chao Gao, et al.
Published: (2020-10-01)

Oral Antiplatelet Therapy for Secondary Prevention of Non-Cardioembolic Ischemic Cerebrovascular Events
by: Leonardo De Luca, et al.
Published: (2021-04-01)

The choice of the P2Y12 receptors blocker in the treatment of a patient with acute coronary syndrome: practice of N.I. Pirogov city clinical hospital №1
by: M. R. Atabegashvili, et al.
Published: (2019-04-01)

Patient after myocardial infarction: how to reduce the risk of recurrent ischemic events?
by: O. L Barbarash, et al.
Published: (2015-06-01)